|
Volumn 31, Issue 5, 2004, Pages 1011-1012
|
Ophthalmologic Monitoring for Antimalarial Toxicity [3] (multiple letters)
a b c c c c |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIMALARIAL AGENT;
CHLOROQUINE;
HYDROXYCHLOROQUINE;
DRUG SAFETY;
EYE TOXICITY;
HUMAN;
LETTER;
PATIENT MONITORING;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
RISK ASSESSMENT;
SYSTEMIC LUPUS ERYTHEMATOSUS;
ANTIMALARIALS;
ARTHRITIS, RHEUMATOID;
DRUG MONITORING;
GREECE;
HUMANS;
HYDROXYCHLOROQUINE;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
PROSPECTIVE STUDIES;
RETINAL DISEASES;
TIME FACTORS;
|
EID: 2342454449
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (4)
|
References (0)
|